Episode Details

Thomas Hopson: Leadership Built to Last

Ep. 41

What is leadership, anyway?

Such a simple question, and yet it continues to vex popular consultants and laypeople alike.  Leadership is a process of social influence, which maximizes the efforts of others, towards the achievement of a goal.

In this episode of DeviceAlliance’s Medtech Radio, we speak with the President of Bioplatte, Thomas Hopson. Thomas Hopson is an accomplished business executive with over 30 years of experience in the medical device industry. Thomas has provided leadership to multi-million-dollar business enterprises in Europe, Asia, and the United States, and he has successfully transformed multiple struggling organizations into healthy and thriving businesses. He joined Bioplate as President in 2018, bringing with him an extensive background in sales, business development, organizational learning, and product commercialization. Before joining Bioplate, Thomas served as the Director, Global Talent Management & Learning at Edwards Life Sciences. Prior to Edwards, Thomas held various leadership positions at St. Jude Medical.

Join us as we discuss his life's journey into leadership, his most valuables mistakes, keeping teams motivated in times of crisis, how to handle making unpopular decisions, and key trends in key trends in the global craniofacial fixation market.

Thomas Hopson Photo

Follow the great work Thomas and team are doing at Bioplate.

Thanks for listening! Please share our podcast on LinkedIn, Twitter, and Facebook, and stay tuned for our next episode!

OTHER MEDTECH RADIO EPISODES

  • All
  • Entrepreneurship/Startups
  • Leadership Spotlight
  • Marketing & Product Development
  • Professional Development
  • Women in MedTech
  • Young Professionals

Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43

You’ve got a great idea for a medical device!  Now what? Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is absolutely crucial for clinical trial success.   With the explosion of Medtech opportunities for startups, what are the current